BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2692600)

  • 1. Lactate dehydrogenase-elevating virus: biology and pathogenesis.
    Cafruny WA
    Crit Rev Microbiol; 1989; 17(2):107-19. PubMed ID: 2692600
    [No Abstract]   [Full Text] [Related]  

  • 2. Lactate dehydrogenase-elevating virus.
    Rowson KE; Mahy BW
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2297-312. PubMed ID: 3903045
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-dependent paralytic viral infection in C58 mice: possible implications in human neurologic disease.
    Murphy WH; Nawrocki JF; Pease LR
    Prog Brain Res; 1983; 59():291-303. PubMed ID: 6320270
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
    Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
    Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection.
    Michaelides MC; Simms ES
    Cell Immunol; 1980 Mar; 50(2):253-60. PubMed ID: 6986993
    [No Abstract]   [Full Text] [Related]  

  • 6. T lymphocyte interaction with viruses and virus-infected tissues.
    Woodruff JF; Woodruff JJ
    Prog Med Virol; 1975; 19():120-60. PubMed ID: 47179
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
    Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
    Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse strain-specific central nervous system lesions associated with lactate dehydrogenase-elevating virus infection.
    Stroop WG; Brinton MA
    Lab Invest; 1983 Sep; 49(3):334-45. PubMed ID: 6887786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The murine antibody response to lactate dehydrogenase-elevating virus.
    Coutelier JP; Van Roost E; Lambotte P; Van Snick J
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1099-108. PubMed ID: 3519860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of viruses on immune response.
    Allison AC; Virelizier JL
    Adv Nephrol Necker Hosp; 1975; 5():115-33. PubMed ID: 171931
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
    van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
    J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes.
    Stevenson MM; Rees JC; Meltzer MS
    J Immunol; 1980 Jun; 124(6):2892-9. PubMed ID: 7373055
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of early splenic changes associated with replication of viruses in murine monocytic macrophages.
    Kenyon AJ
    Am J Vet Res; 1984 May; 45(5):1054-8. PubMed ID: 6329045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathology in viral infections].
    Semenov BF; Gavrilov VI
    Vopr Virusol; 1974; (1):3-7. PubMed ID: 4374809
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection.
    Michaelides MC; Simms ES
    Immunology; 1979 Feb; 36(2):241-6. PubMed ID: 86506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of lactate dehydrogenase elevating virus in mice.
    Stauber E; Burger D; Piper R
    J Comp Pathol; 1975 Apr; 85(2):171-83. PubMed ID: 1141457
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence and other characteristics of the lactate dehydrogenase-elevating virus (LDH-virus).
    Riley V
    Prog Med Virol; 1974; 18(0):198-213. PubMed ID: 4608417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenesis and immunology of lactic dehydrogenase virus (LDV)].
    Inada T; Yamazaki S
    Uirusu; 1987 Dec; 37(2):193-210. PubMed ID: 3328922
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
    Chen Z; Li K; Plagemann PG
    Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of infectious lactic dehydrogenase-elevating virus (LDV) and tumors on macrophage function in mice.
    Meltzer MS
    J Immunol; 1980 Oct; 125(4):1872-3. PubMed ID: 7410857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.